393 related articles for article (PubMed ID: 18369886)
1. Proteomics of cerebrospinal fluid: methods for sample processing.
Hale JE; Gelfanova V; You JS; Knierman MD; Dean RA
Methods Mol Biol; 2008; 425():53-66. PubMed ID: 18369886
[TBL] [Abstract][Full Text] [Related]
2. Proteomics analysis of human cerebrospinal fluid.
Yuan X; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M
Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058
[TBL] [Abstract][Full Text] [Related]
4. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of bronchoalveolar lavage in lung diseases.
Magi B; Bargagli E; Bini L; Rottoli P
Proteomics; 2006 Dec; 6(23):6354-69. PubMed ID: 17133372
[TBL] [Abstract][Full Text] [Related]
6. Detecting nitrated proteins by proteomic technologies.
Butt YK; Lo SC
Methods Enzymol; 2008; 440():17-31. PubMed ID: 18423209
[TBL] [Abstract][Full Text] [Related]
7. Trends in sample preparation for classical and second generation proteomics.
Cañas B; Piñeiro C; Calvo E; López-Ferrer D; Gallardo JM
J Chromatogr A; 2007 Jun; 1153(1-2):235-58. PubMed ID: 17276441
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
9. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
Yuan X; Desiderio DM
Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
[TBL] [Abstract][Full Text] [Related]
10. Methods of comparative proteomic profiling for disease diagnostics.
Steel LF; Haab BB; Hanash SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
[TBL] [Abstract][Full Text] [Related]
11. Surface modified capillary electrophoresis combined with in solution isoelectric focusing and MALDI-TOF/TOF MS: a gel-free multidimensional electrophoresis approach for proteomic profiling--exemplified on human follicular fluid.
Hanrieder J; Zuberovic A; Bergquist J
J Chromatogr A; 2009 Apr; 1216(17):3621-8. PubMed ID: 19155017
[TBL] [Abstract][Full Text] [Related]
12. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
Maurer MH
Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
[TBL] [Abstract][Full Text] [Related]
13. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
14. Detection of new screening markers for fetal aneuploidies in maternal plasma: a proteomic approach.
Reddy CS; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():311-26. PubMed ID: 18425492
[TBL] [Abstract][Full Text] [Related]
15. Classical proteomics: two-dimensional electrophoresis/MALDI mass spectrometry.
Zimny-Arndt U; Schmid M; Ackermann R; Jungblut PR
Methods Mol Biol; 2009; 492():65-91. PubMed ID: 19241027
[TBL] [Abstract][Full Text] [Related]
16. [Proteomic analysis and parasitosis: principles and applications].
Almeras L; Briolant S; Orlandi-Pradines E; Fontaine A; Henry M; Bogreau H; Pradines B; Rogier C; Fusai T
Med Trop (Mars); 2007 Apr; 67(2):188-96. PubMed ID: 17691442
[TBL] [Abstract][Full Text] [Related]
17. Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis.
Tian XJ; Li JY; Huang Y; Xue YP
Chin Med J (Engl); 2009 May; 122(9):1003-8. PubMed ID: 19493432
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.
Rite I; Argüelles S; Venero JL; García-Rodriguez S; Ayala A; Cano J; Machado A
J Neurosci Res; 2007 Dec; 85(16):3607-18. PubMed ID: 17705290
[TBL] [Abstract][Full Text] [Related]
19. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
20. Proteomics in reproductive medicine: the technology for separation and identification of proteins.
Hachey DL; Chaurand P
J Reprod Immunol; 2004 Aug; 63(1):61-73. PubMed ID: 15284006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
